Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc. (ACAD) — Form SCHEDULE 13G: Ownership over 5% (passive)
About this filing
Acadia Pharmaceuticals Inc. (ACAD) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Aug 7, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More ACAD filings
- 4
Filed Oct 30, 2026
- 8-K
Filed Oct 23, 2026
- 8-K
Filed Sep 24, 2026
- 8-K
Filed Sep 11, 2026
- 4
Filed Aug 7, 2026
- 144
Filed Aug 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.